Cargando…

Factors Affecting Best-Tolerated Dose of Pirfenidone in Patients with Fibrosing Interstitial Lung Disease

The aim of the study was to examine the best-tolerated dose of pirfenidone, the adverse effects profile, and potential factors other than drug dose influencing the tolerability of pirfenidone in patients with fibrosing interstitial lung diseases (ILDs). We performed an observational retrospective st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandovra, Neha P., Vaidya, Preyas J., Shah, Ria S., Nighojkar, Aishwarya S., Chavhan, Vinod B., Lohiya, Ayush, Leuppi, Joerg D., Leuppi-Taegtmeyer, Anne, Chhajed, Prashant N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606989/ https://www.ncbi.nlm.nih.gov/pubmed/37892651 http://dx.doi.org/10.3390/jcm12206513

Ejemplares similares

EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy
por: Chhajed, Prashant N., et al.
Publicado: (2019)

The evolution of flexible bronchoscopy: From historical luxury to utter necessity!!
por: Vaidya, Preyas J, et al.
Publicado: (2015)

Parasitic infestation of lung: An unusual cause of interstitial pneumonitis
por: Shah, Parth, et al.
Publicado: (2016)

Inconsistency in the reporting of antitubercular drug susceptibility tests in an endemic region
por: Saha, Avinandan, et al.
Publicado: (2017)

Endobronchial ultrasound transbronchial needle aspiration (EBUS TBNA) in HIV affected individuals: Is the (E)BUS ready for unchartered territories?
por: Agrawal, Neha, et al.
Publicado: (2018)

Predictors of Length of Stay, Mortality and Rehospitalization in COPD Patients: A Retrospective Cohort Study
por: Lüthi-Corridori, Giorgia, et al.
Publicado: (2023)

Audit of Asthma Exacerbation Management in a Swiss General Hospital
por: Schnyder, Dominik, et al.
Publicado: (2023)

Blunt head and neck trauma: Interesting chest tomographic “effect”
por: Vaidya, Preyas, et al.
Publicado: (2016)

Diagnostic Workup and Outcome in Patients with Profound Hyponatremia
por: Isaak, Johann, et al.
Publicado: (2023)

Predictors of Length of Stay, Rehospitalization and Mortality in Community-Acquired Pneumonia Patients: A Retrospective Cohort Study
por: Lüthi-Corridori, Giorgia, et al.
Publicado: (2023)

Resting and Post Bronchial Challenge Testing Carbon Dioxide Partial Pressure in Individuals with and without Asthma
por: Miedinger, David, et al.
Publicado: (2012)

Risk factors for hospital outcomes in pulmonary embolism: A retrospective cohort study
por: Lüthi-Corridori, Giorgia, et al.
Publicado: (2023)

Pre‐treatment comorbidities, C‐reactive protein and eosinophil count, and immune‐related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities
por: Mehra, Tarun, et al.
Publicado: (2023)

Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports
por: Salem, M., et al.
Publicado: (2017)

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
por: Maher, Toby M, et al.
Publicado: (2018)

An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction
por: Török, Salome Schafroth, et al.
Publicado: (2014)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma – a pilot study
por: Kononowa, Nina, et al.
Publicado: (2013)

Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination
por: Bühler, Tim, et al.
Publicado: (2019)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient
por: Bühler, Tim, et al.
Publicado: (2019)

Pirfenidone: is it tolerable?
por: Lara, Abigail, et al.
Publicado: (2016)

Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study
por: Mbata, Munachimso Kizito, et al.
Publicado: (2023)

Effects of pirfenidone on renal function in patients with interstitial pneumonia
por: Matsumoto, Jun, et al.
Publicado: (2021)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Management and support of patients with fibrosing interstitial lung diseases
por: Barbera, Tyonn, et al.
Publicado: (2021)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Role of imaging in progressive-fibrosing interstitial lung diseases
por: Walsh, Simon L.F., et al.
Publicado: (2018)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)

Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19
por: Marzolini, Catia, et al.
Publicado: (2020)

The Correct Indication to Induce Labour in a Swiss Cantonal Hospital
por: Mbata, Munachimso Kizito, et al.
Publicado: (2023)

Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial
por: Gregoriano, Claudia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_66j6h23mk9hui19vlirts27t3s